{"title": "Do multifactor models contribute to estimate the cost of equity capital in Brazil?", "authors": ["Pani, Victor Carneiro.", "Leal, Ricardo Pereira C√¢mara orient.", "Universidade Federal do Rio de Janeiro. Instituto COPPEAD de Administra√ß√£o"], "abstract": "Este estudo investiga a contribui√ß√£o de modelos multifatores de precifica√ß√£o de ativos para estimar o custo do capital pr√≥prio de empresas listadas na bolsa de valores brasileira com o CAPM (Capital Asset Pricing Model), o modelo de tr√™s fatores de Fama e French (1993), o modelo Carhart (1997) de quatro fatores e um modelo de cinco fatores que consiste em um fator de risco adicional de iliquidez. A amostra s√£o os retornos de a√ß√µes individuais que comp√µem a carteira do √≠ndice IBrX 100 de julho de 2008 a junho de 2018. As distribui√ß√µes das estimativas de custo de capital de empresas individuais obtidas com cada modelo foram comparadas entre si no per√≠odo amostral completo e em dois subper√≠odos. Os resultados sugerem que a adi√ß√£o de fatores de risco extras ao CAPM nem sempre se traduz em estimativas diferentes de custo de capital pr√≥prio e em um poder explicativo significativamente maior. A implica√ß√£o pr√°tica √© que as estimativas do CAPM geralmente podem ser as mesmas que as obtidas por meio de modelos mais complexos, com a vantagem adicional da simplicidade do CAPM.", "bibliography_pages": [32, 34], "keywords": ["Finan√ßas.", "Custo de capital.", "Administra√ß√£o Teses."], "urls": ["http://objdig.ufrj.br/41/dissert/914678.pdf", "http://lattes.cnpq.br/4714312241073465"], "pdf_url": "http://objdig.ufrj.br/41/dissert/914678.pdf", "id": "914678", "sentences": ["Resumo", "PANI, Victor. Do multifactor models contribute to estimate the cost of equity capital in Brazil? Rio de Janeiro, 2020. 45 pp. Thesis (Master‚Äôs Degree in Business Administration) - COPPEAD Graduate School of Business, Federal University of Rio de Janeiro, Rio de Janeiro,", "Este estudo investiga a contribui√ß√£o de modelos multifatores de precifica√ß√£o de ativos para estimar o custo do capital pr√≥prio de empresas listadas na bolsa de valores brasileira com o CAPM (Capital Asset Pricing Model), o modelo de tr√™s fatores de Fama e Frenc h (1993), o modelo Carhart (1997) de quatro fatores e um modelo de cinco fatores que consiste em um fator de risco adicional de iliquidez. A amostra s√£o os retornos de a√ß√µes individuais que comp√µem a carteira do √≠ndice IBrX 100 de julho de 2008 a junho de 2018. As distribui√ß√µes das esti mativas de custo de capital de empresas individuais obtidas com cada modelo foram comparadas entre si no per√≠odo amostral completo e em d ois subper√≠odos. Os resultados sugerem que a adi√ß√£o de fatores de risco extras ao CAPM nem sempre se traduz em estimati vas diferentes de custo de capital pr√≥prio e em um poder explicativo significativamente maior. A implica√ß√£o pr√°tica √© que as estimativas do CAPM geralmente podem ser as mesmas que as obtidas por meio de modelos mais complexos, com a vantagem adicional da s implicidade do CAPM .", "Palavras -chave: CAPM, Fama e French, Carhart, precifica√ß√£o de ativos, modelos multifatores, custo de capital. Abstract", "This study investigates the contribution of well -known multifactor asset pricing models to estimate the cost of equity capital of Brazilian listed companies with the Capital Asset Pricing Model (CAPM), the three -factor model of Fama and French (1993), the Carhart (1997) four -factor model and a five -factor model that consists of an additional illiquidity risk factor. The sample are the returns of individual stocks comprising a portfolio of companies in the IBrX 100 stock index from July 2008 to June 2018. Di stributions of individual company cost of equity capital estimates obtained with each model were compared among themselves in the full sample period and two sub - periods. The results suggest that adding extra risk factors to the CAPM does not always transla te into different cost of equity capital estimates and significantly greater explanatory power. The practical implication is that the CAPM estimates may often be the same as those obtained by means of more complex models with the added bonus of the CAPM's simplicity.", "Keyword: CAPM, Fama e French, Carhart, asset -pricing, multifactor models, cost of capital.", "List of tables", "List of Abbreviations", "3F Fama and French three -factor model (1993) 4F Carhart four -factor model (1997) 5F Keene and Peterson five -factor model (2007) B3 Bolsa, Balc√£o e Brasil BG Breusch -Godfrey test BP Breusch -Pagan test CAPM Capital Asset Pricing Model CDI Certificado de Dep√≥sito Interbanc√°rio CFA Chartered Financial Analyst CMA Conservative minus Aggressive DI Dep√≥sito Interbanc√°rio HML High minus Low Ibovespa √çndice da Bolsa de Valores de S√£o Paulo IBrX 100 √çndice Brasil IML Illiquid minus Liquid MRP Market Risk Premium OLS Ordinary Least Squares RMW Robust minus Weak SMB Small minus Big WML Winners minus Losers", "Index", "1-Introduction Investors need the cost of equity capital to price securities and corporate managers require it to make better decisions about investment project s and their funding. Fama and French ( 2004 ) assert that the Capital Asset Pricing Model ( CAPM ) is the most widely used method for estimating the cost of equity capital of a given security and that it has been empirically tested for decades. These authors mention Black, Jensen and Scholes (1972) , who reject ed the traditional form of the CAPM but found a positive relationship between average returns and beta , and Fama and Macbeth (1973) , who suggested that there was a positive relation ship between risk and return , as well as Fama and French (1992) , who argue d that the fitted regression slope of historical returns on beta risk was rather flat, in contrast to the positive slope that was expected. These CAPM problems led Fama and French (1993) to introduce the ir three -factor model (3F) that exhibit ed a greater explanatory power over the CAPM, but displayed significant alphas suggest ing that a portion of the returns remain ed unexplained. Carhart (1997) add ed the momentum factor to the 3F model and found improvements in explanatory power with his four -factor model (4F) relative to the CAPM and 3F for US stock mutual funds . Later on, Keene and Peterson (2007) added an illiquidity factor to the 4F model and found evidence of the superiority of th is five-factor model (5F) in the US stock market.", "The purpose of this study is to investigate if multifactor models offer different and reasonable, in the practical sense, estimates of the cost of equity capital for Brazilian listed companies. Reasonable figures for the cost of equity capital would be those that analysts could consider in real life va luations. For example, figures below the risk free rate are not reasonable as well as those that are too high relative to those of the market or industry peers. This study, thus, aims to answer if the additional complexity that comes with multifactor model s generates estimates of the cost of equity capital that are significantly different from those obtained with the CAPM and with significantly greater explanatory power of the multifactor models . It has been noticed that adding the proper risk factors to th e CAPM improves R¬≤ and produces lower intercepts, however, this does not necessarily translate into better out -of-the-sample estimates of the cost of equity capital because these estimates may be too high for a practical application, as stated in Argolo, L eal and Almeida (2002). The importance to use adequate cost of equity capital estimates in valuation and corporate decision -making is a justification for this study. Inadequate cost of capital estimates may lead to under -investment due to the rejection of good projects when the cost of capital is over -", "estimated. On the other hand, if the cost of capital is under -estimated, one may overpay for an asset or accept projects that are too risky or not as good as one hoped. In a related article, Estrada (2011) estimated the cost of equity capital using the CAPM and 3F models for the 30 companies that make up the Dow Jones Index from 2005 to 2009 and found little difference between the estimates obtained using each model (average difference of -0.2%). Argolo et al. (2012) estimated the out- of-the-sample cost of equity capital of 9 portfolios of Brazilian stocks using the CAPM and the 3F models from 1995 to 2007 and found that estimates obtained with the Fama and French (1993) model could be considered too high to be of practical use, casting doubt on the applicability of the three -factor model in the Brazilian market. Studies have also been carried out to verify the validity of multifactor models to describe the historical returns of Brazilian stocks. Malaga and Secu rato (2004), Santos, Fam√° and Mussa (2011), Rayes, Ara√∫jo and Barbedo (2012) and Machado and Medeiros (2014) are some examples and, in general, they show improvements in the explanatory power of multifactor models over the CAPM and alphas similar to the in ternational literature, even though Rayes et al. (2012) suggest that the 3F model no longer contributes to explain the past return s of Brazilian stocks.", "This study contributes to this domestic literature because it examines estimates for the cost of equity capital of the largest and most liquid listed companies in Brazil, instead of using portfolios of stocks, uses the 4F and 5F models, in addition to the CAPM and 3F models in the Malaga and Securato (2004) and Argolo et al. (2012) studies, uses a more rece nt period in which Rayes et al. (2012) cast doubt about the contribution of the 3F model, and follows a practical approach in examining estimates of the cost of equity capital for each Brazilian company in the IBrX 100 index, following Estrada (2011) and A rgolo et al. (2012) .", "To obtain the coefficients for each model, the return of the IBrX 100 index stocks in excess of the risk -free rate w ere regressed on risk factors. The risk factors were obtained from the Brazilian Center of Research in Finance of the Department of Economics of the University of S√£o Paulo (NEFIN/USP) . These risk factors can be freely downloaded from the NEFIN/USP website and allow for the quick and easy implementation of the 3F, 4F, and 5F multifactor models . Given the applied nature of this investigation, other multifactor models whose risk factors are not easily obtained, were not the considered in this study. The coefficients obtained for each risk factor of each model were multiplied by estimates of the expected value of the correspo nding risk factor to obtain the cost of equity capital estimates for each company. The study then analyses the", "distribution of these estimates and the differences among them as well as the marginal contribution of each additional risk factor for each compa ny.", "The results show that the means of the cost of equity capital obtained with the four-factor and five -factor model are different from the CAPM estimates for the full sample period . The CAPM beta is positive and significant for the vast majority of stoc ks whereas most coefficients of the additional factors in the multifactor models are not positive and significant. The Wald test results suggest that the extra risk factors provide little contribution to the explanation of returns and, in most cases, should not be included in the models. The estimates obtained with the CAPM seem to be at least as good as those obtained using multifactor models with the added bonus of simplicity, which is an important practical implication of this st udy.", "2- Literature Review 2.1 ‚Äì The Development of Multifactor Models The cost of equity capital remains a central point of discussion in the finance literature due to its importance in valuation. The traditional for m of the CAPM has been widely used in organizations as w ell as taught in business schools (Estrada, 2011 ; Fama and French, 2004 ). Graham a nd Harvey (2001) conducted a survey with 392 Chief Financial Officers ( CFOs ) in the US and Canada and found that 73 .5% of them use the CAPM . Welch (2008) found that 75% of finance professors recommend the use of the CAPM to compute the cost of equity capital . Bancel and Mittoo (2014) surveyed 365 valuation experts across 10 European countries that hold a Chartered Financial Analyst ( CFA ) or similar designation and found that nearly 80% of them use the CAPM. The popularity of the CAPM can be attributed to its simplicity (Fama and French, 2004) . The main idea behind the model is that the return of a given security can be explained as a function o f market risk. Based on strong assumptions, the model has received many criticisms , such as the one from Roll (1977) , who argue d that the market portfolio cannot be obtained, hence the CAPM cannot be tested .", "In the 1980s, e vidence began to emerge suggesting that new factors could play a role on the explanation of average returns. Fama and French (2004) report on some return anomalies or regularities that other authors identified, highlighting the small capitalization stocks effect, revealed through the persistent larger returns of small companies, and the value stocks effect, suggested by the better performance of high book -to-market (BE/ME) ratio stocks relative to those", "with low BE/ME. Considering that these regularities should be priced, Fama and French (1992) proceeded to assess the ones that contribute d to explain the cross -section of average expected US stock returns. They indicate d that BE/ME was a better representative of the value effect than the earnings -price ratio (E/P) and even of the le verage effect. The Fama and French (1993) three -factor model , thus, resulted from this line of research and include d factors based on the size and value effect s as additional risk factors to the CAPM's market risk premium (MRP) . The risk factors in addition to the MRP consist ed of portfolios that mimic the size effect, yielding a small stock risk premium , and the value stock effect, yielding a value stock risk premium, measured using the BE/ME ratio. In order to test the ir model, Fama and French ( 1993) used the time-series regression methodology documen ted in Black et al. (1972) where stocks are grouped into portfolios and their excess returns were regressed on risk factors. The MRP was obtained by taking the value -weighted monthly return of a port folio of stocks listed on the three largest US stock exchanges of the time in excess of the US Treasury bill.", "To obtain the small minus big factor (SMB) , which is the portfol io that accounts for the size anomaly , listed common stocks were ranked by size (number of stocks outstanding times the market value of the stock) and the median was taken to divide the sample into small (S) and big (B) stocks . Similarly, they ranked the same unive rse of stocks sorted by BE/ME and divided it into three groups : the top 30% (H) ; the medium 40% (M) and the low 30% (L). Six p ortfolios of stocks were then formed combining two of each one of the S, B, H, M, and L portfolios. The SMB factor was calculated monthly from July of year t to June of year t+1 according to Equation 1. The HML factor was calculated for the same period of SMB according to Equation 2. ùëÜùëÄùêµ =ùëÜùêø+ùëÜùëÄ+ùëÜùêª 3‚àíùêµùêø+ùêµùëÄ +ùêµùêª ùêªùëÄùêø =ùëÜùêª+ùêµùêª 2‚àíùëÜùêø+ùêµùêø The sample stocks were then ranked once again by size and gro uped into five quintiles. Then, they were sorted by BE/ME within each quintile group and grouped into five BE/ME quintiles in each size quintile portfolio, forming 25 portfolios . Fama and French (1993) used the value -weighted returns of these portfolios to empirically test the ir three -factor model from 1963 to 1991 and concluded that it fared better in the attempt to explain the cross -section of average stock returns than the CAPM . The 3F model was then applied in many world markets and Griffin (2002) concluded that domestic versions of the 3F model were better at explaining returns than a world", "three -factor model in a study about the usefulness of domestic, world and international versions of the Fama and French (1993) model.", "The size and value anomalies were naturally not the only regularities identified in the literature . Fama and French (2004) report ed that the momentum effect was the most serious challenge faced by the 3F model . The momentum effect was documented in Chan, Jegadeesh and Lakonishok (1996) by means of a strategy that yields a positive return by holding stocks that performed well in the last 12 months and shorting those that performed poorly during the same period. Fama and French (1996) assert ed the three -factor model c ould not explain the momentum effect. Liu , Strong and Xu (1999) showed that past winner stocks offered future abnormal returns in the UK as well and that the three -factor model did not account for this effect. Carhart (1997) then added the winner minus los er risk factor (WML) to the Fama and French (1993) model to obtain a four-factor model.", "Amihud (2013) reported on another anomaly related to market illiquidity identified in his previous works. He argued that ex pected market illiquidity displayed a positive and significant impact on ex ante excess stock return s. Keene and Peterson (2007) added the illiquid minus liquid (IML) risk factor to the Carhart (1997) four-factor model. They found that IML explain ed a portion of the shared variation in US st ock returns in the period from 1963 to 2002. This 5-factor model was used in Keene and Peterson (2007) and in this study as well.", "Other multifactor models have been proposed in the literature. They will not be the focus of this study because their risk fac tors are not readily available for Brazilian stocks yet and, thus, given the applied nature of this investigation, this renders it more difficult for practitioners to use them to estimate the cost of equity capital. One of the se models is the Fama and Fren ch (2015) five-factor model that adds the investment ( Conservative minus Aggressive - CMA) and the profitability (Robust minus Weak - RMW) factors to their 3F model . The authors tested th is new model from 1963 to 2013 in the US market and found that it explain ed between 71% to 94% of the cross -section variation of expected returns of the portfolios examined.", "2.2 ‚Äì Multifactor models in Brazil The earlier Brazilian evidence about the size and value anomalies was not always consistent with the US eviden ce. Costa Jr. and Neves (2000) investigated which variables better contributed to explain the cross -section of average returns in a study comprising 117 stocks listed in the S√£o", "Paulo stock exchange from 1986 to 1996. They found that the most significant r isk factors were the market risk premium and the BE/ME ratio, similarly to the Fama and French (1992) results. Braga and Leal (2002) tested the anomalies considered in Fama and French (1992) for the Brazilian market from 1991 to 1998. The sample contained 423 stocks and they used the Sharpe Index to evaluate the risk -return relationship among portfolios. They found that the portfolios built with high BE/ME stocks significantly outperformed the low BE/ME ones, in line with Fama and French (1992). However , the size effect was not statistically significant. Leal and Rodrigues (2003) investigated the Fama and French (1993) model in the period of 1991 to 2001 and also found evidence supporting the value effect in the Brazilian market, however, the sign of the coefficients of the size premium was negative suggesting a large company effect that was contrary to the international literature. M√°laga and Securato (2004) analyzed the period of from 1995 to 2003 with a sample containing all non -financial listed stocks that had 12 consecutive months of stock price s and non -negative shareholder equity at the end of the preceding year. They found that the 3F model offer ed superior explanatory power on the variation of returns compared to the CAPM. The coefficient of the size premium (SMB) was negative , in line with previous Brazilian findings and contrary to Fama and French (1993).", "Argolo et al. (2012) also tested the Fama and French (1993) model in the Brazilian market from 1995 to 2007 and compared it to the CAPM , but their goal was to ascertain whether the three - factor model could provide reasonable out-of-the-sample estimates of the cost of equity capital . They built nine portfolios of stocks in a way similar to the Fama and French (1993) approach and ran ordinary least squares ( OLS ) regression s to estimate the coe fficients for the CAPM and the 3F model. They found that the CAPM beta was significant at a 5% level in all portfolios. Moreover, beta remained significant in the three -factor model and 5 out of 9 portfolios had the three coefficients significant at a 5% level. The adjusted R¬≤ increased with the addition of the risk factors, similar to previous studies (M√°laga and Securato, 2004; Fama and French 1993).", "Subsequently, these authors estimated the cost of equity capital for each portfolio using historical averages as estimates for the expected value of each risk factor and multiplied these expected risk factor estimates by their correspondi ng regression coefficients . They concluded that these cost of equity capital estimates were too high for the three -factor model to be useful estimate in practical cost of capital applications . This study will follow the procedure in Argolo et al. (2012).", "As examples of more recent tests of multifactor models in Brazil, Rayes et al. (2012) tested the Fama and French (1993) model for 40 stocks from 2000 to 2008. They grouped stocks into equally weighted and value weighted portfolios . In addition, they tested the Fama and French (1993) model with individual stocks. They found that the beta coefficient is significant for most regressions but the Fama and French (1993) factors no longer explain the variation of returns for these Brazilian stocks , in contrast to previous articles.", "Mussa, Fam√° and Santos (2012) investigated the Carhart (1997) model in Brazil from 1995 through 2006. They compared their findings to the CAPM and the three -factor model of Fama and French (1993). The authors concluded that the 4F model offered greater explanatory power relative to the 3F model and that the 3F model showed greater explanatory power relative to the CAPM. The authors also highlighted the fact that the coefficient of SMB was negative, contrary to international literature but corroborating previous Brazilian studies such as M√°laga and Securato (2004) and Leal and Rodrigues (2003).", "Finally, r egarding the illiquidity factor, Vieira and Milach (2008) investigated a series of proxies for liquidity and found that the bid-ask sprea d as well as the illiquidity factor ha d a positive relationship w ith expected returns in a study for the 1995 -2005 period . Machado and Medeiros (2011) also analyzed whether a n illiquidity premium exists in the Brazilian stock market and if it contributed to the explanation of expected returns when included in a multifactor asset pricing model and concluded in favor of its inclusion. Later, Machado and Medeiros (2014) investigated anomalies commonly associated with asset pricing with Brazilian stocks from 1995 to 2008. They examined the effects of size, book -to-market, momentum, liquidity, earnings -price, cash flow -to- price and leverage on returns and found no statistical significance for the size effect, earnings -price and leverage. However, they found tha t book -to-market, liquidity and momentum were significant at the 1% level , consistently with previous Brazilian studies .", "3- Methodology", "3.1 Sample", "The sample consists of the stocks that made up the IBrX 100 in October of 2018 , which was the time of data collection . The composition of the IBrX 100 changes periodically due to the eligibility criteria used to select the stocks that comprise it, however, in this study, no changes were made in the sample, keeping the same 100 stocks that comprised the index in Oct ober of 2018 over", "the full period. The IBrX 100 portfolio was chosen because it has more stocks than the Ibovespa, yielding a larger sample. The index contains the 100 most representative and traded stocks in Brasil Bolsa Balc√£o (B3), as the consolidated Brazilian exchange is currently known , because it considers their market value and liquidity in the inclusion criteria. The sample period goes from July 2008 to June 2018 in order to obtain a 10 -year sample ending at the time of data collection . All stocks with less than 36 consecutive monthly observations were deleted from the sample, resulting in 91 stocks for the full sample period. The 10 -year period was chosen because a longer period would result in a bigger number of stocks being deleted from the sample due to the exclusion criterion. The stocks deleted from the sample and their num ber of observations can be found in Appendix 1. No exclusions were made regarding the simultaneous presence of common or preferred stocks , so a company could have both kinds of stocks considered in the analysis. One should note that preferred stocks in Bra zil are simply similar to common stocks but usually offer no voting rights. They do not commonly offer fixed dividends. The IBrX 100 is weighted by the market value of the free floating shares while t he Ibovespa was weighed by market liquidity up to Decemb er of 2013 and only after this point it began to be weighted by the market value of free floating shares (Roquete, Leal and Campani, 201 8). In spite of their differences, t hese indices have a correlation of 98,7% in the sample period .", "The dividend and split adjusted monthly closing stock prices and the Interfinancial Certificate of Deposit (C DI) rate monthly yield were obtained from the Economatica database. The CDI was chosen to compute the excess returns of stocks because the CDI is the st andard benchmark of the opportunity cost of investors and, as such, it is commonly reported in the factsheets of mutual funds in the country . It display ed a 99% correlation with the short -term Brazilian Treasury bill rate (Roquete et al., 2018) . The monthl y stock returns were calculated using Equation 3, where Rs,t is the month t return of stock s, Ps,t is the closing price of the last trading day of month t of stock s and Ps,t-1 is the closing price of the last trading day of month t-1 of stock s. The monthly returns of the MRP, SMB, HML, WML, and IML risk factors were obtained from NEFIN/USP and the procedures described below are those detailed in NEFIN (2015 ). The market portfolio is the one used by NEFIN/USP and is made up of the most traded stock of a firm (the one with the highest trading volume of year t-1). In addition, a market portfolio stock has to be traded in more than 80% of the days in year t-1 with volume greater than R$ 500.000,00 per day", "and must be list ed prior to December of year t-1. NEFIN /USP uses the daily equivalent of the 30- day DI Swap rate as the risk-free rate . This is a fixed for floating swap rate. NEFIN /USP computes the difference between the value -weighted monthly return of the ir market portfolio and the monthly return of the ir risk-free rate to obtain the MRP . The MRP computed using t he IBrX 100 and the Ibovespa is the monthly return of the index minus the CDI monthly yield. These monthly risk premia have a correlation of 9 9.5% and 98 .2%, respectively, with the MRP computed by NEFIN/USP, which is the MRP representation in this study .", "SMB is the return of a portfolio long on stocks with low market capitalization (small) and short on stocks with high market capitalization (big). Ev ery January of year t, the eligible stocks are sorted in ascending order according to their December of year t-1 market capitalization. The stocks are then se parate d into 3 terciles. The equal ly-weighted returns of the first portfolio (small stocks) and the third portfolio (big stocks) are then computed. The SMB factor is the return of the small stocks portfolio minus the return of the big stocks portfolio (NEFIN, 2015).", "HML is the return of a portfolio long on stocks with high BE/ME ratios and short on stocks with low BE/ME ratios. Every January of year t, the eligible stocks are sorted in ascending order into 3 terciles (portfolios) according to the BE/ME ratio of the stocks in June of year t-1. Then, the equal ly-weighted returns of the first portfolio (low BE/ME ) and the third portfolio (high BE/ME ) are computed . The HML factor is the return of the high BE/ME stock portfolio minus the return of the low BE/ME stock portfolio (NEFIN, 2015) .", "WML is the return of a portfolio long on stocks with high past re turns and short on stocks with low past returns. Every month t, the eligible stocks are sorted in ascending order and divided into 3 terciles (portfolios) according to their cumulative returns between month t-12 and t-2. Then, the equal ly-weighted returns of the first portfolio (low past returns, i.e., ‚Äúlosers‚Äù) and the third portfolio (high past returns, i.e.,‚Äù winners‚Äù) are computed . The WML factor is the return of the winners ' portfolio minus the return of the losers ' portfolio (NEFIN, 2015) .", "Finally, IML is the return of a portfolio long on illiquid stocks ( high illiquidity ) and short on liquid stocks ( low illiquidity ). Every month t, the eligible stocks are sorted in ascending order and divided into 3 terciles (portfolios) according to their previous t welve -month moving average of illiquidity, as in Amihud (20 13). Then, the equal -weighted returns of the first ( high illiquidity) and the third portfolio s (low illiquidity) are computed . The IML factor is the return of the illiquid stocks portfolio minus th e return of the liquid stocks portfolio (NEFIN, 2015) .", "3.2 Regression models", "Time -series regressions with robust standard errors were used to estimate the coefficients for each model. The robust standard errors provide a way to obtain consistent (in the statistical sense) estimates of the variances and covariances of OLS estimators even if there is heteroscedasticity (Gujarati, 2004, p. 417). According to Fama and French (1993), the be nefits of using time -series regressions are twofold: (1) if assets are priced rationally, variables such as size and BE/ME that are related to average returns, must proxy for sensitivity to common risk factors in returns ; and (2) excess returns are used in the dependent variable as in the independent variables and , therefore, the regression should produce intercepts that are indistinguishable from 0. The expression s for the CAPM, three -factor, four -factor and five -factor models are in Equations 4 to 7, respectively , where ùëÖùë†,ùë°‚àíùëÖùëìùë° is the monthly return of stock s in excess of the risk free rate (CDI), MRP, SMB, HML, WML, and IML risk factors were described above, and ùúÄùë° is the residual of the model. The correlation among the MRPs computed using CDI a nd the DI swap are very close to 1, thus, the DI swap and the CDI could be used interchangeably.", "3.3 Cost of equity capital computation", "The estimates of each risk factor used in this study to estimate the expected cost of equity capital are the a rithmetic average of the monthly returns for the full period of data available in the NEFIN/USP website , which was from Jan uary of 2001 to June of 2018 at the time of data collection . The reason for choosing the longest period available is due to the stand ard error being smaller, similarly to Estrada (2011) who estimated the cost of equity capital for individual stocks using the Fama and French (1993) risk factors averaged from 1927 -2009. The use of the arithmetic average, as pointed out in Ibbotson Associates (2007), can be shown to be more suitable when dealing with expected rate of return, as opposed to geometric averages which are better for reporting past returns. After obtaining the set of coefficie nts for each individual stock with each model, the cost of equity capital was estimated for every stock through the multiplication of each risk factor average in Table 1 by the corresponding estimated risk factor coefficient. After", "multiplying each risk fa ctor average by its respective estimated coefficient, the full-period (2001 - 2018) risk-free (CDI) average is added to estimate the cost of equity capital . The result is then annualized. Equation 8 describes the procedure for the single -factor model . ùëÖùëí is the expected rate of return of any given stock and ùëÖùëìùë° is the risk free rate (CDI).", "The risk factor portfolios obtained from NEFIN/USP are provided as daily returns. To compute the monthly averages in Table 1 the cumulative returns are necessary. The cumulative returns are obtained by adding 1 to the daily return of the risk factor and then multiplying the result of day t by the result of the previous day. After the cumulative returns were computed, the accumulated return o n the last trading day of month t is divided by the accumulated return of the last trading day of the month t-1 and subtracted by 1. This procedure is similar to the one used to compute the monthly return of stocks in this study.", "Table 1. Monthly arithmetic average of risk factors and risk free rate Risk -Free MRP SMB HML WML IML Correlation - Sample period (2008 -2018) MRP SMB HML WML IML Note. The full sample period goes from July 2008 to June 2018. The full time series of the risk factors in the NEFIN/USP database went from January 2001 through June 2018.", "In order to compare the asset -pricing model s, the adjusted R¬≤ will be analyzed. A Wald test will be performed to assess the contribution of each risk factor to the models. As a robustness test, a sub-period analysis will be carried out. The full sample (July 2008 through June 2018) stands for period A (120 observ ations). The sub-period B contains the most recent period (July 2013 through June 2018) with 60 observations and the period of July 2008 through June 2013 is sub-period C also with 60 observations . The same methodology used for estimating the cost of equit y capital for", "group A was used for the sub-periods. Sub-period B has 91 stocks and sub -period C has 84 stocks . This is due to the previously mentioned criterion of deleting any stocks from the sample that has less than 36 monthly observations as well as du e to the sample selection consisting of the IBrX 100 portfolio in October 2018. Naturally, as one goes towards pa st periods, some companies listed in October 2018 were not listed yet .", "4- Results Appendix 2 contains the estimated cost of equity capital for individual stocks for the full sample period from July 2008 to June 2018 (Group A) using the CAPM and the multifactor models. The three rightmost columns are the differences between the estimated cost of equity capital with each model. Table 2 contains a summary of the estimates and of the differences with descriptive statistics and the p -value of the Shapiro -Wilk normality test. The average difference between CAPM estimated cost of equity capital and the o ther models is very low. Normality is rejected for the 3F cost of capital distribution and for three difference distributions at the 5% level . The differences distributions show a high dispersion. It is also interesting to note that the CAPM estimates of the cost of equity capital shows the smallest range and standard deviation. The additional factors seem to increase the variability of the distribution of the cost of equity capital. However, the ad dition of IML relative to the 4F model does not seem to change the distribution of the cost of equity capital at all, as it displays very a small range and standard deviation.", "Table 2. Descriptive statistics of the cost of equity capital Variable Mean T- stat. Median Z- stat. Std. Dev. Max Min SW N Note. Null hypothesis for the t -test is that the mean of the distribution is equal to zero. Null hypothesis of the Wilcoxon signed -rank test is that the median is equal to zero (z -stat). \"SW\" is the Shapiro -Wilk normality test and its null hypothesis is that the population is normally distributed. 3F is the Fama and French three -factor model. 4F is the Carhart (1997)", "four-factor model. 5F is the five -factor model of Keene and Peterson (2007). 3F -CAPM, 4F -CAPM, 4F -3F, 5F -CAPM, 5F-3F and 5F -4F are the average differences between the estimated cost of equity capital between these pairs of models. ** and * indicate significance at the 1% and 5% levels, respectively.", "Table 2 also shows the results for the one-sample t-test of the means and the Wilcoxon signed rank test of the medians for the estimates in Appendix 2. The results are consistent with Estrada (2011). The t -test assumes that the population is normal ly distributed and the Wilcoxon test is a non -parametric hypothesis test. The null hypotheses of the t-test of the means are rejected for the difference distributions 4F -CAPM and 5F -CAPM , suggesting that the means are different, however, for the remaining differences distributions, the null hypotheses could not be rejected, sugg esting their means and medians are the same and null across models .", "Table 3. Average regression d iagnostics Model Adj R¬≤ F Ramsey Test (p - value) VIF BP (Chi¬≤) BG (Chi¬≤) N Note. The numbers in parenthesis are the count of regressions that exhibit a diagnostic problem . The Ramsey Test tests for omitted variables . VIF is the mean of the Variance Inflation Factor and tests for multicollinearity with a threshold of 10 . BP is the Breusch -Pagan test for heteroscedasticity . BG is the Breusch -Godfrey test for serial correlation. 3F is the Fama and French three -factor model. 4F is the Carhart (1997) four -factor model. 5F is the five - factor model of Keene and Peterson (2007). All values are averages except for N.", "Table 3 shows the averages o f selected diagnostics of the regressions. The individual results for each regression can be found with the authors. The Ramsey Regression Equation Specification Error Test (RESET) is used to verify if there is a general functional form misspecification. T he null hypothesis for the RESET test is that the mo del is correctly specified. The average p -value for the diagnostics su ggest s that the n ull hypothesis cannot be reject ed for more than two -thirds of the models. The variance inflation factor (VIF) quantifies by how much the variance of each estimated coefficient is inflated. The standard errors, and therefore the variances, are considered inflated when there is multicollinearity. Setting a threshold value for VIF in order to conclude that multicollinearity exists is arbitrary. Ofte n times, the value 10 is chosen to decide that multicollinearity is a problem ( Wooldridge, 2008, p. 99). The CAPM VIF is naturally 1 since it is a single -factor model, as mor e factors are added, the VIF tends to increase due to a possible", "correlation among the dependent variables, nevertheless, the average variance inflation factor is not high enough to indicate that there is any multicollinearity problem in the models . The nu ll hypothesis of the Breusch -Pagan (BP) test is that the error variances are all equal versus the alternative hypothesis that the error variances are different. In essence, the BP test measures how errors increase across the explanatory variable. The average chi-square value of the test in Table 3 suggests that there is no heteroscedasticity in more than two -thirds of the models . Finally, the Breusch -Godfrey (BG) test verifies the presence of serial correlation in the model. The null hypothesis states that there is no serial correlation. The average in Table 3 suggests that there is no serial correlation in the residu als in all models .", "Appendix 3 exhibits the estimated cost of equity capital with the adjusted R¬≤ for each regression. It can be noted that the adjusted R¬≤ increases as more risk factors are added . Showing all individual coefficients for each model would be impractical, thus, Table 4 summarizes them and shows their mean and significance level s as well as the number of positive and signifi cant coefficients in parenthesis . Even though t he average alpha, beta and ‚Äòs‚Äô coefficients in Table 4 are significant ly different from zero for the four models , there are very few significant alphas in the individual models . This apparent contradiction is due to their standard deviation being close to their average, producing a high t -statistics. The average beta is close but below 1 and nearly all of them are positive and significant in the individual regressions , consistently with previous Brazilian studies such as Rayes et al. (2012) and Machado and Medeiros (2011) . The averages of \"s\" are positive and nearly 30% of them are positive and significant in the individual models. Thus, in most cases, \"s\" is not posit ive or significant, consistently with previous Brazilian studies such as Rayes et al. (2012) and Malaga and Securato (2004). It is also interesting to note that the presence of the IML risk factor has reduced the number of positive and significant \"s\" coef ficients, this is probably due to the high correlation of 80% between SMB and IML portrayed in Table 1 . The average s of the ‚Äòh‚Äô , 'w', and 'i' coefficient s are not statistically significant for the four model s tested and very few models presented \"w\" and \"i \" significant . The small number of positive and significant \"h\" coefficients is consistent with the more recent evidence in Rayes et al. (2012). However, th e very few positive and significant \"w\" and \"i\" coefficients for individual stocks contrasts with th e results of Santos et al. (2011) and Machado and Medeiros (2011) for portfolios of stocks. For the three -factor model, only 2 regressions have all of their coefficients positive and significant at the same time and for the 4F and 5F model s, no regression showed these results. The", "adjusted R¬≤ increase s as more factors are added, as expected, however this information alone does not suffice to determine if a more complex model provides better estimates of the cost of equity. Table 4. Average of Model Coefficients Model Alpha Beta s h w i Significant N Note. The number of positive and significant coefficients are in parenthesis. Alpha is the intercept. Beta is the coefficient of the MRP. \"s\" is the coefficient of SMB. \"h\" is the coefficient of HML. \"w\" is the coefficient of WML. \"i\" is the coefficient of IML. \"Significant\" is the number of regressions with all coefficients positive and significant. N is the number of stocks (models). ** and * indicate significant at the 1% and 5% levels, respectively, for the null hypothesis that the average coefficient is 0. A Wald test assesses the contribution that each additional risk factor brings to the CAPM model . The results are in Table 5. The Wald test, as described in Agresti (1990 , p. 12), is a way of testing whether the coefficients associated with one or a group of explanatory variables are zero. If the Wald test is significant for a specific explanatory v ariable or group of variables, then it is possible to conclude that the parameters associated with these variables are not zero and that they should be included in the model. If, on the other hand , the test is not significant, the variables should not be included in the model. An F stat istics equal or greater than 4 is usually significant at a 5% level , depending on the degrees of freedom . Table 5. Wald Test Model Null Hyp. F Null Rejection N", "Note. 3F_CAPM indicates the contribution of the two additional factors of 3F relative to the CAPM. The same logic follows in the other rows. F is the average of the individual F statistics. ‚ÄúNull Rejection ‚Äù shows the number of coefficients that are signifi cant at the 5% level for the Wald Test. N is the number of models (stocks).", "The 3F_CAPM test tries to answer if the two additional factors in the three -factor model (SMB and HML) add to the explanation of average returns relative to the CAPM . In this case , the null hypothesis states that the coefficient ‚Äòs‚Äô and ‚Äòh‚Äô are both equal to zero. In 39 out of 91 regressions , the F statistics was significant, and therefore, for these specific cases, the SMB and HML factors should be included in the model. The same rationale can be applied to each of the other rows in Table 5 . The 5F_4F test shows that only in 9 cases out of 91 the IML factor should be added to the 4F model, casting doubt on the applicability of th is five-factor model for any given stock . Adding the WML factor to the Fama and French model (4F_3F) does not seem to provide a large improvement since only in 16 cases the momentum risk factor adds to the explanation of returns. Also, when taking into account the results of Table 4, in which the ‚Äòw‚Äô coefficient was positive and significant in only 6 cases out of 91, the addition of the WML risk factor seems to be dismissible for estimating the cost of equity capital of individual stocks in this sample . The results for \"h\", \"w\", and \"i\" contrast with those presented in Machado and Medeiros (2011) and Santos et al. (2011) for portfolios of stocks. Thus, the multifactor models do not seem to generate significant coefficients for individual stocks.", "5- Sub-Period Analysis In order to verify stability across time, the sample was divided into two sub-period s. Sub- period B is the most recent half of the full sample period (July 2013 through June 2018) and sub- period C is the oldest half (July 2008 through June 2013). Appendixes 4 and 5 contain the estimated cost of equity capital for the sub-period s. Table 6 shows the descriptive statistics for the estimated cost of equity capital and the difference distributions as well as the p -value of the Shapiro -Wilk normality test for each sub-period . The n ormality of the cost of equity capital distribution s is not rejected for various models and differences distributions. There is evidence to suggest that the means of the estimated cos t of equity capital with each model, when compared among them , are the same at the 5% level , except for 4F and 5F relative to the CAPM in sub -period B . The numbers", "also suggest that the medians of the 3F , 4F and 5F are different relative to the CAPM at the 5% level . The results in Panel A are similar to those for the full period, with the exception of the results of the Wilcoxon test . Panel B results suggest that the means and medians of the cost of equity capital of the four models are the same , similarly to the full period with the exception of the means of 4F and 5F relative to the CAPM . The behavior of the dispersion of the distributions in the sub - periods is similar to what was verified in the full period.", "Table 6. Descriptive statistics of the cost of equity capital per sub -period Variable Mean T-stat. Median Z-stat. Std. Dev. Max Min SW N Note. Null hypothesis for the t -test is that the mean of the distribution is equal to zero. Null hypothesis of the Wilcoxon signed -rank test is that the median is equal to zero (z -stat). \"SW\" is the Shapiro -Wilk normality test and its null hypothesis is th at the population is normally distributed. 3F is the Fama and French three -factor model. 4F is the Carhart (1997) four -factor model. 5F is the five -factor model of Keene and Peterson (2007). 3F -CAPM, 4F -CAPM, 4F -3F, 5F - CAPM, 5F -3F and 5F -4F are the average differences between the estimated cost of equity capital between these pairs of models. ** and * indicate significant at the 1% and 5% levels, respectively.", "Table 7 show s the summary of the diagnostics of the regressions for the sub-period s. Panel A of Table 7 shows the diagnostics for the most recent period. Ten CAPM regressions out of 91 exhibit functional form misspecification. Since it is a single -factor model, multicollinearity would", "not be a problem. No heteroscedasticity and serial corr elation was found for the CAPM. The numbers show that between 1 0 and 16 models out of the 91 show a misspecification as well as a heteroscedasticity problem. Panel B of Table 7 shows similar diagnostics for sub -period C. In a similar way, no model shows a multicollinearity problem or serial correlation of the residuals. 21 out of 84 regressions show general form misspecification and 7 show a heteroscedasticity problem for the CAPM. The rest of the models perform similarly. For sub-period C, the CAPM seems t o present more regression problems than the other models. There were fewer models with problems in the sub -periods than in the full sample period. Table 7. Average regression diagnostics by sub -periods Model Adj R¬≤ F Ramsey Test (p - value) VIF BP (Chi¬≤) BG (Chi¬≤) N Note. The numbers in parenthesis are the count of regressions that exhibit a diagnostic problem . The Ramsey Test tests for omitted variables. VIF is the mean of the Variance Inflation Factor and tests for multicollinearity with a threshold of 10 . BP is the Breusch -Pagan test for heteroscedasticity. BG is the Breusch -Godfrey test for serial correlation. 3F is the Fama and French three -factor model. 4F is the Carhar t (1997) four -factor model. 5F is the five -factor model of Keene and Peterson (2007). All values are averages except for N.", "Table 8 show s the mean of the coefficients of the regressions and their statistical significance for the sub-period s. Panel A of Table 8 shows that t he average alpha and beta are statistically significant for the four models, the average ‚Äòs‚Äô is significant for the 3F and C arhart (1997) models and the remainder average coefficients are not significantly different from zero. No", "multifactor models have all of their coefficients positive and significant at the same time. The results are not very different in Panel B. The results for the full period are similar to the ones obtained for the sub -periods. Table 8. Summary of Coefficients - Sub-periods Model Alpha Beta s h w i Significant N Note. The number of positive and significant coefficients are in parenthesis. Alpha is the intercept. Beta is the coefficient of the MRP. \"s\" is the coefficient of SMB. \"h\" is the coefficient of HML. \"w\" is the coefficient of WML. \"i\" is the c oefficient of IML. ‚ÄúSignificant‚Äù is the number of regressions with all of their coefficients positive and significant. N is the number of stocks (models). ** and * indicate significant at the 1 % and 5% levels, respectively, for the null hypothesis that the average coefficient is 0.", "Table 9. Wald test - Sub-periods B and C Sub-period B Sub-period C Model Null Hyp. F Null Rejection N F Null Rejection N", "Note. 3F_CAPM indicates the contribution of the two additional factors of 3F relative to the CAPM. The same logic follows in the other rows. F is the average of the individual F statistics. ‚ÄúNull Rejection ‚Äù shows the number of coefficients that are signifi cant at the 5% level for the Wald Test. N is the number of models (stocks).", "Table 9 shows the Wald test for the two sub -periods. The SMB and HML factors add to the explanation of returns and, therefore, improve the CAPM performance in 26% of the cases for sub- period B and 33% of the cases for sub-period C. The same rationale can be applied to the rest of the tests. There is little gain in adding the fifth risk factor (IML) to the Carhart (1997) model in both sub-periods . Similarly, the ri sk factors WML and IML do not improve significantly on the three -factor model. In general, the Wald test shows that the extra risk factors added to the CAPM fail to provide significant explanatory power for the model for most stocks . The SMB and HML factors should not be included in the model to estimate the cost of equity capital for individual stocks in 67 cases out of 91 for sub-group B and in 56 out of 84 for the sub-group C. The number of regressions that should not bear extra risk factors is alarmingly large . The results for the full period show superior performance when assessing the contribution of extra risk factors to the CAPM compared to the sub -periods. However, in more than half of the regressions of the full period , the additional risk fa ctors should not be included in the CAPM.", "6- Conclusion The purpose of this study was to understand if multifactor asset -pricing models offer different estimates of the cost of equity capital relative to the CAPM for individual stocks as well as to ascertain if the additional risk factors present an explanatory power gain . The results suggest that the means of the cost of equity capital estimated with the four -factor and five -factor models are different from the CAPM in the full sample period and also in the most recent su b-period. However, the evidence suggest s that the medians are the same in the full period and in the oldest sub-period. Thus, there is no clear and conclusive evidence that the estimates of the cost of equity capital of the multifactor models are in general different from those produced by the CAPM. In addition, most coefficients for multifactor regressions are not positive and significant. To decide which model to use based solely on the adjusted R¬≤ analys is wou ld be misleading because", "the resulting estim ate is built upon coefficients that are indistinguishable from zero in most cases. The Wald test was carried out i n order to assess the contribution of each factor to the models with similar results for the full perio d and sub-period s. The additional risk factors should not be included in the models in the majority of cases . The coefficient s of the SMB and HML risk factor s were significant for the Fama and French (1993) model in 27 and 17 out of 91 regressions, re spectively . Moreover, these coefficients are only positive and significant together in the same regression in only 2 cases. For the Carhart (199 7) and the five -factor model, no regression showed all coefficients positive and significant at the same time. For most regressions, the market risk premium coefficient beta was positive and significant. Moreover, the average intercept was positive and significant ly different from zero for the four models, even though very few of them were significant in the individ ual regressions.", "This study raises concern about the applicability of multifactor models for individual stocks in the Brazilian marke t, which is consistent with the conclusions of Argolo et al. (2012) for portfolios of stocks . Thus, a practical implication is that estimates of the cost of equity capital obtained with the CAPM seem to be at least as useful, in most cases, as those obtained with multifactor models, which is important given the simplicity of the CAPM despite the ma ny criticisms it has received over the years. Even though the multifactor models show higher adjusted R¬≤ when compared to the CAPM, the results imply that the complexity that come s with multifactor models in general outweigh the possible benefits.", "Multifa ctor models have been extensively tested in the Brazilian market using portfolio s of stocks (Rayes et al., 2012; Santos et al., 2012; Machado and Medeiros, 2011) . A limitation of this study is that t he estimates obtained running time -series regressions for individual stocks may be jeopardized by higher variances compared to those of portfolios of stocks , even though estimates of the cost of equity capital are important for individual stocks . Additionally, the high volatility in 2008 and 2009 , the financial crisis year and the following rebound year, may have affected the sample . An interesting approach would be to group stocks of similar characteristics, such as f rom the same industry or size group, into portfolios in order to minimize variance, and to verify if a multifactor model would consistently offer better estimates of the cost of equity capital for the Brazilian market industries in a period of more stability , even though the earlier results of Argolo et al. (2012) suggest that this would not happen . A final limitation of this study is that it relies on the historical averages of each risk factor as estimates of their expected values. Even though it may", "be easy to obtain alternative expected values for the MRP and the risk free rate, alternati ve estimates for the other risk factors are not so economically intuitive. Future research could discuss the issue of which estimates are better for the expected values of the risk factors for a practical application setting.", "References AGRESTI, A. Categorical Data Analysis . New York: John Wiley and Sons, 2nd edition, 1990. AMIHUD, Y. Illiquidity and Stock Returns: Cross -Section and Time -Series Effects. Journal of Financial Markets , ARGOLO, E .F. B.; LEAL , R. P. C.; ALMEIDA, V. S. O modelo de Fama e French √© aplic√°vel ao Brasil? Rio de Janeiro: UFRJ/Coppead, 2012. (Relat√≥rios Coppead 402) BANCEL, F. ; MITTOO, U. R. The gap between theory and practice of firm valuation: Survey of European valuation experts. Journal of Applied Corporate Finance , v. 26, n. 4, p. 106 -117, 2014. BLACK, F.; JENSEN, M. C. ; SCHOLES, M. The Capital asset pricing model: Some empirical tests. In: JENSEN, M. (Org.) Studies in the Theory of Capital Markets , 1st ed., New York: Praeger, 1972. p.79-121. BRAGA, C. M.; LEAL, R. P. C. A√ß√µes de valor e crescimento nos anos 90. In: BONOMO, M. A. (Org.). Finan√ßas Aplicadas no Brasil . Rio de Janeiro: FGV, 2002. p. 235 -248. CARHART, M. M.. On Persistence in Mutual Fund Performance. Journ al of Finance , v. 52, n. 1, p. 57 -82, 1997 . CHAN, L.K.C. ; JEGADEESH, N. ; LAKONISHOK, J. Momentum Strategies. The Journal of Finance , v. 51, n. 5, p. COSTA J R., N. C. A. ; NEVES, M. B. E. Vari√°veis fundamentalistas e os retornos das a√ß√µes. Revista Brasileira de ESTRADA, J. The Three -Factor Model: A Practitioner's Guide. Journal of Applied Corporate Finance , v. 23, n. 2, FAMA, E.F. ; FRENCH, K.R.. The cross -section of expected stock returns. Journal of Finance , v. 47, n. 2 , p. 427 - FAMA, E. F.; FRENCH, K. R. Common risk factors in the returns on stocks and bonds. Journal of Financial FAMA, E. F.; FRENCH, K.R. Multifactor Explanations of Asset Pricing Anomalies. Journal of Finance , v. 51, n. 1, FAMA, E. F.; FRENCH, K. R. The Capital Asset Pricing Model: Theory and evidence. Journal of Economic FAMA, E. F. ; FRENCH, K. R. A five -factor asset pricing model. Journal of Financial Economics , v. 116, n. 1, p. 1 -", "VVAR11 0 WISZ3 0", "Appendix 2. Estimated cost of equity capital with different models. Stocks CAPM 3F 4F 5F 3F- CAPM 4F- CAPM 5F- CAPM", "Note: This table contains the cost of equity capital estimated for 91 stocks. Period: July/2008 to June/2018. 3F is the Fama and French (1993) three -factor model, 4F is the four -factor model of Carhart (1997), 5F is the five -factor model as per Keene and P eterson (2007). \"Mean\" is the arithmetic average.", "Appendix 3. Estimated cost of equity and adjusted R¬≤ Stocks CAPM Adj R¬≤ (CAPM) 3F Adj R¬≤ (3F) 4F Adj R¬≤ (4F) 5F Adj R¬≤", "Note: This table contains the cost of equity capital estimated for 91 stocks. Period: July/2008 to June/2018. Appendix 4. Estimated cost of equity capital - Sub-period B Stocks CAPM 3F 4F 5F 3F- CAPM 4F- CAPM 5F- CAPM", "Appendix 5. Estimated cost of equity capital - Sub-period C Stocks CAPM 3F 4F 5F 3F- CAPM 4F- CAPM 5F- CAPM"]}